05.01.13
Rizk |
Rizk has had experience working with payers, hospital systems, government, physicians and pharmaceutical companies. Since 2003, he has served as president of McKesson Health Solutions, a business unit of McKesson Corporation, which delivers clinical evidence and expert technology to help payers and providers collaborate for better healthcare outcomes at lower costs. Prior to joining McKesson, Rizk served as senior partner and global director of Deloitte Consulting, where he led medical cost and quality management across segments.
“We are pleased to welcome Dr. Rizk to the board of directors of Accuray,” said Joshua H. Levine, president and CEO of Accuray. “Dr. Rizk’s extensive leadership experience, strong track record of growth and intimate understanding of the needs and concerns of all healthcare industry stakeholders, make him a vital addition to the board.”
“I am delighted to join Accuray’s board of directors,” said Rizk. “Accuray’s advanced radiation therapy technologies, the Cyberknife and Tomotherapy Systems, are perfect examples of how innovative medical technology enables hospitals and physicians to deliver superior, efficient and cost-effective patient care.”
Rizk has served on healthcare boards including the National Clinical Advisory Board and National Quality Review, and currently serves on the boards of the Care Continuum Alliance, National Association for Hispanic Health, University of Miami, University of North Texas, and Managed Care magazine. He also is a senior scholar professor at Jefferson Medical College in Philadelphia, Pa.
Accuray focuses on radiation technology in the oncology space.